SPTX
Seaport Therapeutics, Inc. Common Stock • NASDAQ
$18.19 ▼ -3.24% (-0.61)
SPTX
Seaport Therapeutics, Inc. Common StockNASDAQ • $18.19 ▼ -3.24% (-0.61)
Market Cap $964.58 M
52w High $23.00
52w Low $14.85
P/E -9.38
Volume 112.57K
Outstanding Shares 53.03M
Market Cap $964.58 M
52w High $23.00
52w Low $14.85
P/E -9.38
Volume 112.57K
Outstanding Shares 53.03M
About Seaport Therapeutics, Inc. Common Stock
https://www.seaporttx.comSeaport Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines. The company develops therapeutic candidates for conditions such as depression and anxiety disorders using its proprietary Glyph technology platform.
CEO
Daphne Zohar
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Biotechnology
Sector Healthcare
Went public May 1, 2026
Method of going public IPO
Full time employees 58
Price Target
Target High $35
Target Low $30
Target Median $32.5
Target Consensus $32.5